Devices › Device types
FDA product code LXB · class 2 · Ear, Nose, Throat
Hearing aid, bone conduction: medical device reports filed with FDA
7,135 reports carry this product code, 2003–2026; 18 brands with a page.
- 7,135
- reports with this product code
- 0% of all MAUDE reports
- 283
- reports, 12 months to August 2026
- 249 in the 12 months before
- 0.6%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code LXB is FDA's classification for "Hearing aid, bone conduction" (ear, Nose, Throat panel), a class 2 device. 7,135 medical device reports carry this product code, 0% of the MAUDE database, from November 2003 to August 2026.
283 reports arrived in the 12 months to August 2026, up 14% from 249 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.3%), other (0.9%) and malfunction (0.6%). 18 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Flange Fixture And Abutment | 2,821 | 0 | 0% | 0.3% |
| BIM400 Implant Magnet | 1,131 | 153 | 0% | 0.6% |
| Asku | 515 | 210 | 1.1% | 47.1% |
| BI300 Implant 4 mm | 299 | 28 | 0% | 0.6% |
| Baha Flange And Abutment | 188 | 0 | 0% | 1.1% |
| Flange Fixture St 4mm W Baha Abutment | 182 | 9 | 0% | 0% |
| Bi300 Implant 3mm | 168 | 19 | 0% | 0% |
| BIA400 Implant 4mm w Abutment 12mm | 20 | 35 | 0% | 0.1% |
| BIA400 Implant 4mm w Abutment 10mm | 17 | 68 | 0% | 0% |
| BIA400 Implant 4mm w Abutment 8mm | 13 | 33 | 0% | 0% |
| Ba400 Abutment 8mm | 11 | 7 | 0% | 0.3% |
| BA400 Abutment 12mm | 7 | 21 | 0% | 0% |
| BA400 Abutment 10mm | 6 | 18 | 0% | 0% |
| BIA400 Implant 4mm w Abutment 14mm | 5 | 25 | 0% | 0.5% |
| Nucleus 24 Channel Cochlear Implant System | 2 | 0 | 0.1% | 40.3% |
| Cochlear Osia OSI200 Implant | 1 | 247 | 0.1% | 3.8% |
| Nucleus 24 Contour | 1 | 56 | 0% | 31.7% |
| Nucleus CI422 Cochlear Implant with Slim Straight Electrode | 1 | 52 | 0% | 13.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Cochlear Bone Anchored Solutions | 7,008 | 98.2% |
| Oticon Medical | 64 | 0.9% |
| Cochlear | 24 | 0.3% |
| Medtronic Xomed | 9 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Loss of osseointegration | 1,212 | 17% |
| Patient device interaction problem | 619 | 8.7% |
| Insufficient device problem information | 265 | 3.7% |
| Failure to osseointegrate | 260 | 3.6% |
| Expulsion | 70 | 1% |
| Device dislodged or dislocated | 40 | 0.6% |
| Component falling | 35 | 0.5% |
| Inadequacy of device shape and/or size | 30 | 0.4% |
| Therapeutic or diagnostic output failure | 30 | 0.4% |
| Device remains implanted | 29 | 0.4% |
| Patient-device incompatibilitythe device did not suit the patient | 29 | 0.4% |
| Extrusion | 25 | 0.4% |
| Explanted | 24 | 0.3% |
| Signal artifact/noise | 23 | 0.3% |
| Biocompatibility | 20 | 0.3% |
| Detachment of device component | 17 | 0.2% |
| Device slipped | 13 | 0.2% |
| Device operates differently than expectedthe device behaved unexpectedly | 11 | 0.2% |
| Loosening of implant not related to bone-ingrowth | 11 | 0.2% |
| Output problem | 11 | 0.2% |
Questions about hearing aid, bone conduction reports
What is product code LXB?
FDA's classification code for "Hearing aid, bone conduction", class 2, reviewed by the ear, Nose, Throat panel. Every device report carries the product code of the device involved.
How many reports carry this code?
7,135 reports through August 2026, 283 of them in the latest 12 months.
Which brands appear most often?
Flange Fixture And Abutment (2,821), BIM400 Implant Magnet (1,131), Asku (515), BI300 Implant 4 mm (299) and Baha Flange And Abutment (188). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.